S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

ASX:ANR - Anatara Lifesciences Stock Price, Forecast & News

Today's Range N/A
50-Day Range
A$0.24
MA: A$0.28
A$0.40
52-Week Range N/A
Volume48,600 shs
Average VolumeN/A
Market Capitalization$12.64 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Anatara Lifesciences Limited engages in the development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia. Its lead product includes Detach, a non-antibiotic treatment to aid in the control of diarrhoeal diseas. The company is also developing bromelain formulations for gastrointestinal health. Anatara Lifesciences Limited is based in Brisbane, Australia.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 7 3394 8202

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$663,405.00
Book ValueA$0.12 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$12.64 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ANR News and Ratings via Email

Sign-up to receive the latest news and ratings for ANR and its competitors with MarketBeat's FREE daily newsletter.


Anatara Lifesciences (ASX:ANR) Frequently Asked Questions

What is Anatara Lifesciences' stock symbol?

Anatara Lifesciences trades on the ASX under the ticker symbol "ANR."

Has Anatara Lifesciences been receiving favorable news coverage?

News coverage about ANR stock has been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Anatara Lifesciences earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Anatara Lifesciences.

Who are some of Anatara Lifesciences' key competitors?

What other stocks do shareholders of Anatara Lifesciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anatara Lifesciences investors own include Brompton Oil Split Cl A (OSP), Eagle Materials (EXP), BHP Group (BHP), Ameriprise Financial (AMP) and Woodside Petroleum (WPL).

Who are Anatara Lifesciences' key executives?

Anatara Lifesciences' management team includes the folowing people:
  • Dr. Tracie Elizabeth Ramsdale, Interim CEO & Exec. Director (Age 56)
  • Dr. Tracey Mynott, Co-Founder, Chief Scientific Officer and R&D Director
  • Dr. Michael L. West Ph.D., Chief Operating Officer (Age 55)
  • Dr. Terence Jean Brown, Chief Devel. Officer (Age 56)
  • Mr. Alan Dowling, Group Accountant

How big of a company is Anatara Lifesciences?

Anatara Lifesciences has a market capitalization of $0.00 and generates $663,405.00 in revenue each year. View Additional Information About Anatara Lifesciences.

What is Anatara Lifesciences' official website?

The official website for Anatara Lifesciences is http://www.anataralifesciences.com/.

How can I contact Anatara Lifesciences?

The company can be reached via phone at 61 7 3394 8202.


MarketBeat Community Rating for Anatara Lifesciences (ASX ANR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  25
MarketBeat's community ratings are surveys of what our community members think about Anatara Lifesciences and other stocks. Vote "Outperform" if you believe ANR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel